HuGE Literature Finder
Records 1-5
The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2015 Feb 69 208-13. Zhou Lingling, Zhang Gang, Zhou Xiaoguang, Li J |
Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Gynecologic oncology 2013 Mar 128 (3): 584-9. Li Yan, Hao Ya-li, Kang Shan, Zhou Rong-miao, Wang Na, Qi Bing- |
FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.
PloS one 2013 8 (9): e74543. Xu Lei, Zhou Xin, Jiang Feng, Qiu Man-Tang, Zhang Zhi, Yin Rong, Xu L |
Fas gene promoter -670 polymorphism in gynecological cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 0 16 Suppl 1 (): 179-82. Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Yamaguchi H, Nishiyama K, Yasuda M, Ueki |
Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
Anticancer research 0 27 (2): 991-4. Gormus Uzay, Ergen Arzu, Yilmaz Hulya, Dalan Burak, Berkman Sinan, Isbir Turg |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: